Library — CHDR

Search

Filter

Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers.

Dumont GJ, Wezenberg E, Valkenberg MM, de Jong CA, Buitelaar JK, van Gerven JM, Verkes RJ

Psychopharmacology, 2008 Mar; 197(3):465-74

View publication
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.

de Haas SL, de Visser SJ, van der Post JP, Schoemaker RC, van Dyck K, Murphy MG, de Smet M, Vessey LK, Ramakrishnan R, Xue L, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2007 Dec; 22(1):24-32

View publication
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.

de Haas SL, de Visser SJ, van der Post JP, de Smet M, Schoemaker RC, Rijnbeek B, Cohen AF, Vega JM, Agrawal NG, Goel TV, Simpson RC, Pearson LK, Li S, Hesney M, Murphy MG, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2007 May; 21(4):374-83

View publication
Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol.

Hazekamp A, Ruhaak R, Zuurman L, van Gerven J, Verpoorte R

Journal of pharmaceutical sciences, 2006 Jun; 95(6):1308-17

View publication
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.

Dumont GJ, de Visser SJ, Cohen AF, van Gerven JM,

British journal of clinical pharmacology, 2005 Apr; 59(5):495-510

View publication
Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.

van der Post JP, de Visser SJ, Schoemaker RC, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2004 May; 18(2):221-7

View publication
The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic system.

Gijsman HJ, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2004 Feb; 18(1):7-13

View publication
No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity.

van der Post J, de Waal PP, de Kam ML, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2004 Feb; 18(1):109-14

View publication
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers.

Rijnbeek B, de Visser SJ, Franson KL, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2003 Jun; 17(2):196-203

View publication

«
1
2
...
6
7
8
9
10
11
12
13
14
»